Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472), a global leader in pharmaceutical manufacturing, today announced that it has been named a winner of the World Finance Sustainability Awards 2025, in recognition of its industry-leading efforts to embed sustainability into the heart of its operations. This accolade underscores Bora’s ongoing commitment and achievements in responsible manufacturing, community health, and long-term environmental stewardship.
In 2024, Bora took decisive steps to align with science-based targets, enhance ESG disclosures, and invest in greener, more efficient pharmaceutical manufacturing practices across its global network. “We’re proud to be recognized among global leaders who understand that sustainability is not optional, it is a business imperative that can improve stakeholder trust,” said Bobby Sheng, Chairman and CEO of Bora Pharmaceuticals.
From lowering carbon intensity and reducing hazardous waste to strengthening workforce wellbeing and community ethics, Bora continues to set new benchmarks in the CDMO and specialty pharma space.
The World Finance Sustainability Awards celebrate organizations that go beyond compliance and actively contribute to climate resilience, social equity, and sustainable innovation. Bora is honored to be part of this year’s cohort and remains committed to driving real-world impact for patients, partners, and the planet.
For full winner list: https://www.worldfinance.com/awards/world-finance-sustainability-awards-2025